Alpine Global Management’s Inhibrx INBX Stock Holding History

Alpine Global Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12,445	Closed	-$176K	–	293
2024 Q2	$176K	Buy	+12,445	New	+$194K	0.03%	322

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alpine Global Management's INBX Position: Q3 2024 in Review

Alpine Global Management sold out of Inhibrx (INBX) in Q3 2024, closing a stake of 12,445 shares — an estimated $176K sold.

Alpine Global Management first reported a position in INBX in Q2 2024 and held it in 1 quarter. The position peaked at $176K in Q2 2024. 96 funds tracked by Wall St. Rank hold INBX as of Q3 2024.

Alpine Global Management reported no remaining Inhibrx position as of Q3 2024 after selling out during the quarter.
Alpine Global Management sold 12,445 Inhibrx shares in Q3 2024, an estimated $176K.
Alpine Global Management first reported a position in Inhibrx in Q2 2024 and held it in 1 quarter.
Alpine Global Management's Inhibrx position peaked at $176K in Q2 2024.
96 funds tracked by Wall St. Rank held Inhibrx as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.